Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial
PURPOSE: Fatigue is a distressing symptom occurring in more than 60% of patients with cancer. The CNS stimulants modafinil and methylphenidate are recommended for the treatment of cancer-related fatigue, despite a limited evidence base. We aimed to evaluate the efficacy and tolerability of modafinil...
Príomhchruthaitheoirí: | , , , , , , , , , , |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
American Society of Clinical Oncology
2014
|